Suchergebnisse - "Hites, Maya"

PubPharm (9)

1

Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis : pooled data from two prospective randomised controlled trials

enthalten in: The Lancet. Infectious diseases | 2024

von Thompson, G. | Soriano, A. | Honore, P. | +14

2

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care (London, England) | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +154

3

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE) : a multicentre, double-blind, double-dummy, randomised phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Thompson, G. | Soriano, A. | Cornely, O. | +113

CommentIn: Lancet. 2023 Jan 7;401(10370):3-5. - PMID 36442483

4

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy) : a phase 3, randomised, controlled, open-label trial

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +115

CommentIn: Lancet Infect Dis. 2021 Sep 14;:null. - PMID 34534513

5

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2022

von Bravo, L. | Smolenov, I. | Han, H. | +44

CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704

6

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Declercq, J. | Van Damme, K. | De Leeuw, E. | +40

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1353-1354. - PMID 34756179

7

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

8

Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005-2019

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2021

von Graux, E. | Hites, M. | Martiny, D. | +4

9

Epidemiology and clinical impact of viral, atypical, and fungal respiratory pathogens in symptomatic immunocompromised patients : a two-center study using a multi-parameter customized respiratory Taqman® array card

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2019

von Steensels, D. | Reynders, M. | Descheemaeker, P. | +4

1
[1]